Gastric Cancer Screening in Common Variable Immunodeficiency

Individuals with common variable immunodeficiency (CVID) have an increased risk of gastric cancer, and gastrointestinal lymphoma, yet screening for premalignant gastric lesions is rarely offered routinely to these patients. Proposed screening protocols are not widely accepted and are based on gastri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical immunology 2018-10, Vol.38 (7), p.768-777
Hauptverfasser: van der Poorten, David K., McLeod, Duncan, Ahlenstiel, Golo, Read, Scott, Kwok, Avelyn, Santhakumar, Cositha, Bassan, Milan, Culican, Suzanne, Campbell, David, Wong, Sue W. J., Evans, Louise, Jideh, Bilel, Kane, Alisa, Katelaris, Constance H., Keat, Karuna, Ko, Yanna, Lee, Jessie A., Limaye, Sandhya, Lin, Ming Wei, Murad, Ari, Rafferty, Martina, Suan, Dan, Swaminathan, Sanjay, Riminton, Sean D., Toong, Catherine, Berglund, Lucinda J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Individuals with common variable immunodeficiency (CVID) have an increased risk of gastric cancer, and gastrointestinal lymphoma, yet screening for premalignant gastric lesions is rarely offered routinely to these patients. Proposed screening protocols are not widely accepted and are based on gastric cancer risk factors that are not applicable to all CVID patients. Fifty-two CVID patients were recruited for screening gastroscopy irrespective of symptoms or blood results and were compared to 40 controls presenting for gastroscopy for other clinical indications. Overall, 34% of CVID patients had intestinal metaplasia (IM), atrophic gastritis or moderate to severe non-atrophic gastritis, which can increase the risk of gastric cancer, compared to 7.5% of controls ( p  
ISSN:0271-9142
1573-2592
DOI:10.1007/s10875-018-0546-3